metaEvidence - overview


			deaths (OS)	progression or deaths (PFS)	RFS/DFS
MIBC - NA - PDL1 positive muscular invasive bladder cancer (MIBC) MIBC - (neo)adjuvant (NA) MIBC - NA - PDL1 positive
versus placebo
	nivolumab alone vs. placebo	1	-	-	-1636 [-2785; -487] /10000 54/140 vs. 78/142